WALDENSTRÖM'S MACROGLOBULINEMIA
Clinical trials for WALDENSTRÖM'S MACROGLOBULINEMIA explained in plain language.
Never miss a new study
Get alerted when new WALDENSTRÖM'S MACROGLOBULINEMIA trials appear
Sign up with your email to follow new studies for WALDENSTRÖM'S MACROGLOBULINEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare blood cancer: zanubrutinib trial targets untreated patients
Disease control OngoingThis study tests the drug zanubrutinib (Brukinsa) in 18 Chinese adults who have Waldenström macroglobulinemia but have not yet received any treatment. The goal is to see how well the drug controls the disease and to check for side effects. Participants take zanubrutinib by mouth,…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Phase: PHASE4 • Sponsor: BeiGene • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New pill shows promise for tough blood cancers in early trial
Disease control OngoingThis early-stage study tests an oral drug called MK-1026 in 12 Chinese adults with blood cancers (like lymphoma or leukemia) that returned or didn't respond to prior therapies. The main goals are to check the drug's safety and how the body processes it. Researchers will also look…
Matched conditions: WALDENSTRÖM'S MACROGLOBULINEMIA
Phase: PHASE1 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 12:26 UTC